Danish Pharmacovigilance Update, September 2014

07 October 2014

The September issue of Danish Pharmacovigilance Update.

News from the EU

  • Denosumab (Prolia and Xgeva) and risk of osteonecrosis of the jaw and hypocalcaemia, page 2
  • Interferon beta and risk of serious adverse reactions, page 4

News from the DHMA

  • Scopoderm® transdermal patches and visual disturbances, page 5
  • Childhood vaccinations and reported suspected adverse reactions in Q2 of 2014, page 6

Short news

  • Most recent Direct Healthcare Professional Communications (DHPCs), page 13

Did you get answers to your questions?

Please tell us how we can improve our website? Please note that we do not answer questions asked via this feature.